Home › Funds › ASHFORD CAPITAL MANAGEMENT INC › LGND

ASHFORD CAPITAL MANAGEMENT INC position in LGND

LIGAND PHARMACEUTICALS INC · Health Care

ASHFORD CAPITAL MANAGEMENT INC reported holding 166,336 shares of LGND (LIGAND PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$52.0M, representing 5.62% of its reported portfolio and ranking #1 among its reported holdings. ASHFORD CAPITAL MANAGEMENT INC has disclosed LGND holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)166.34K sh
Reported value held$51.96M
Portfolio Weight5.62%
First reportedQ1 2024
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How ASHFORD CAPITAL MANAGEMENT INC's LGND position evolved

ASHFORD CAPITAL MANAGEMENT INC first disclosed a stake in LGND in Q1 2024 at 196,535 shares (US$14.4M). The position peaked in Q2 2026 at 170,236 shares, worth US$53.8M. Across 11 filings, ASHFORD CAPITAL MANAGEMENT INC increased the stake 2 time(s), trimmed it 7 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 166,336 shares valued at US$52.0M — a reduction of -3,900 shares quarter over quarter.. Notable position changes include a 64% increase in Q2 2024 (shares rose 19% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 196.53K $14.37M New
Q2 2024 322.21K $27.15M Add
Q3 2024 310.41K $31.07M Reduce
Q4 2024 310.66K $33.29M Hold
Q1 2025 298.04K $31.34M Reduce
Q2 2025 302.53K $34.39M Add
Q3 2025 244.43K $43.30M Reduce
Q4 2025 213.78K $40.42M Reduce
Q1 2026 207.56K $41.44M Reduce
Q2 2026 170.24K $53.81M Reduce
Q3 2026 166.34K $51.96M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LGND and 13F data

LGND (LIGAND PHARMACEUTICALS INC) is a Health Care company. 48 other funds we track also report a position in LGND — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$205.7M), Chicago Capital, LLC (US$172.2M), Stephens Investment Management Group LLC (US$139.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LGND

All LGND fund holders →

FAQ

How long has ASHFORD CAPITAL MANAGEMENT INC held LGND?

ASHFORD CAPITAL MANAGEMENT INC has disclosed LGND holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is ASHFORD CAPITAL MANAGEMENT INC's current position in LGND?

As of Q3 2026, ASHFORD CAPITAL MANAGEMENT INC holds 166.34K shares of LGND (LIGAND PHARMACEUTICALS INC), valued at $51.96M, representing 5.62% of its reported portfolio and ranking #1.

Has ASHFORD CAPITAL MANAGEMENT INC been buying or selling LGND?

In the latest 13F filing (Q3 2026), ASHFORD CAPITAL MANAGEMENT INC reduced its position in LGND. The position peaked in Q2 2026 at 170.24K shares.

Which other funds hold LGND?

Other major institutional holders of LGND include CONGRESS ASSET MANAGEMENT CO, Chicago Capital, LLC, Stephens Investment Management Group LLC, among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.